Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

60%

Ph phase_4

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 4Post-market surveillance

2(40.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Detailed Status

Completed3

Withdrawn1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 42 (40.0%)

N/A3 (60.0%)

Trials by Status

withdrawn120%

recruiting120%

completed360%

Recent Activity

1 active trials

Showing 5 of 5

recruitingnot_applicable

Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension

NCT07181564

withdrawnnot_applicable

Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors

NCT00555984

completedphase_4

Clinical Trials (5)

Showing 5 of 5 trials

NCT07181564Not Applicable

Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension

Recruiting

NCT00555984Not Applicable

Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors

Withdrawn

NCT00611195Phase 4

Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI

Completed

NCT02151305Not Applicable

Different Hemostasis According to the Anesthetic Agents

Completed

NCT01720615Phase 4

Detection of Consciousness by EEG and Auditory Evoked Potentials

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5